PBYI

Puma Biotechnology, Inc.

$8.53 +0.13 (+1.55%) At close · Jul 17

Market Cap

$434.17M

50,899,456

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$931,333	—	$551,549	$535,513	$1,027,307	$16,635	$3,062,337
Jeff Ludwig	CEO	$264,880	—	$132,998	$129,131	—	$949,159	$1,476,167
Maximo Nougues	CFO	$562,961	$130,607	$170,848	$165,881	$191,069	$19,849	$1,241,215
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$489,060	$122,265	$133,765	$129,878	$165,987	$20,445	$1,061,400

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$904,207	—	$1,055,548	$1,055,354	$938,612	$16,210	$3,969,931
Maximo Nougues	CFO	$538,719	$123,905	$275,433	$275,392	$172,067	$19,462	$1,404,978
Alvin Wong	Chief Scientific Officer	$413,683	—	$275,433	$275,392	—	$374,263	$1,338,769
Jeff Ludwig	CEO	$608,499	$60,850	$172,146	$172,119	$194,355	$20,320	$1,228,288
Chief Regulatory Affairs	Medical Affairs, and Pharmacovigilance Officer	$461,892	$106,235	$241,006	$240,965	$147,528	$19,875	$1,217,501
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$461,892	$106,235	$241,006	$240,965	$147,528	$19,875	$1,217,501

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$877,871	—	$818,309	$821,842	$407,991	$18,735	$2,944,748
Jeff Ludwig	CEO	$596,568	$77,554	$294,007	$295,277	$85,309	$33,134	$1,381,848
Alvin Wong	Chief Scientific Officer	$524,160	$99,590	$275,433	$275,392	$74,955	$15,535	$1,265,064
Maximo Nougues	CFO	$515,521	$108,259	$257,258	$258,366	$73,720	$18,702	$1,231,826
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$428,026	$89,885	$211,317	$212,231	$61,208	$18,886	$1,021,553
Chief Regulatory Affairs	Medical Affairs, and Pharmacovigilance Officer	$428,026	$89,885	$211,317	$212,231	$61,208	$18,886	$1,021,553

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$852,302	—	$393,360	$394,837	$877,530	$14,732	$2,532,761
Jeff Ludwig	CEO	$573,623	$131,933	$91,145	$91,486	$181,724	$29,572	$1,099,483
Maximo Nougues	CFO	$495,693	$114,009	$144,870	$145,417	$157,036	$14,732	$1,071,757
Alvin Wong	Chief Scientific Officer	$504,000	$115,920	$104,575	$104,970	$159,667	$30,104	$1,019,237
Chief Regulatory Affairs	Medical Affairs, and Pharmacovigilance Officer	$398,164	$91,578	$52,768	$52,966	$126,138	$16,767	$738,381
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$398,164	$91,578	$52,768	$52,966	$126,138	$16,767	$738,381

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$827,478	—	$1,802,411	$15,540,659	$268,930	$14,132	$18,453,610
Maximo Nougues	CFO	$472,089	$94,418	$668,252	$668,160	$47,209	$14,132	$1,964,260
Jeff Ludwig	CEO	$562,375	$89,980	$433,549	$433,485	$56,238	$26,416	$1,602,043
Alvin Wong	Chief Scientific Officer	$459,364	$96,000	$84,692	$651,954	$48,000	$22,424	$1,362,434
Chief Regulatory Affairs	Medical Affairs, and Pharmacovigilance Officer	$379,204	$75,841	$237,479	$237,443	$37,920	$16,075	$983,962
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$379,204	$75,841	$237,479	$237,443	$37,920	$16,075	$983,962

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$834,276	—	$1,574,004	$1,574,009	$417,756	$13,782	$4,413,827
Jeff Ludwig	CEO	$435,417	$807,500	—	$1,978,445	$66,000	$4,451	$3,291,813
Richard P. Bryce	Chief Medical and Scientific Officer	$501,555	$85,264	$630,031	$534,008	$80,249	$17,974	$1,849,081
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$364,619	$87,509	$534,001	$534,008	$58,339	$15,498	$1,593,974
Maximo Nougues	CFO	$460,575	$87,509	$192,010	$151,579	$73,692	$13,782	$979,147

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$779,978	$506,986	$1,088,608	$1,366,618	—	$13,132	$3,755,322
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$350,595	$161,724	$518,544	$336,014	—	$11,960	$1,378,837
Richard P. Bryce	Chief Medical and Scientific Officer	$482,264	$221,841	$274,824	$336,014	—	$16,196	$1,331,139
Steven Lo	Chief Commercial Officer	$468,507	—	—	$792,034	—	$57,438	$1,317,979
Maximo Nougues	CFO	$445,000	$207,667	—	—	—	$13,132	$665,799

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Douglas Hunt	Chief Regulatory Affairs, Medical Affairs and Pharmacovigilance Officer	$329,690	$149,147	—	$6,272,963	—	$2,792	$6,754,592
Alan Auerbach	CEO	$757,260	$541,441	$2,169,303	$2,672,286	—	$12,260	$6,152,550
Maximo Nougues	CFO	$71,029	$550,000	—	$1,660,455	—	$158	$2,281,642
Steven Lo	Chief Commercial Officer	$468,918	$206,324	—	$1,548,743	—	$12,291	$2,236,276
Richard P. Bryce	Chief Medical and Scientific Officer	$468,217	$206,015	$547,650	$657,043	—	$14,886	$1,893,811

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Alan Auerbach	CEO	$732,527	$404,362	—	$1,640,430	—	$10,566	$2,787,885
Steven Lo	Chief Commercial Officer	$455,261	$200,314	—	$738,193	—	$12,502	$1,406,270
Richard P. Bryce	Chief Medical and Scientific Officer	$430,475	$175,013	—	$738,193	—	$12,630	$1,356,311

Key facts CIK 1401667 CUSIP 74587V107 13F (30d) 16 filings 11 filers Visit website Investor relations